Simulect 20 mg pulbere pentru soluţie injectabilă/perfuzabilă

Country: Մոլդովա

language: ռումիներեն

source: AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

active_ingredient:

Basiliximabum

MAH:

Novartis Pharma AG

ATC_code:

L04AC02

INN:

Basiliximabum

dosage:

20 mg

pharmaceutical_form:

pulbere pentru soluţie injectabilă/perfuzabilă

units_in_package:

N1

prescription_type:

cu prescripție

manufactured_by:

Novartis Pharma Stein AG, Elveţia

authorization_date:

2023-01-31

PIL

{"timestamp":"2024-04-11T11:22:57.622+0000","status":405,"error":"Method
Not
Allowed","message":"Request method 'GET' not
supported","path":"/api/view-
document"}

SPC

{"timestamp":"2024-04-11T11:22:52.231+0000","status":405,"error":"Method
Not
Allowed","message":"Request method 'GET' not
supported","path":"/api/view-
document"}